Primary Site >> Liver Cancer

Gene >> IFIT1

Journal: Clin Pharmacol Ther. 2011 Nov;90(5):712-21.
Title: Genetic variants of interferon-stimulated genes and IL-28B as host prognostic factors of response to combination treatment for chronic hepatitis C.
Author: Lopez-Rodriguez, R|Trapero-Marugan, M|Borque, M J|Roman, M|Hernandez-Bartolome, A|Rodriguez-Munoz, Y|Martin-Vilchez, S|Abad-Santos, F|Munoz de Rueda, P|Vidal-Castineira, J R|Rodrigo, L|Salmeron, J|Moreno-Otero, R|Sanz-Cameno, P
PMID: 21993426
Journal: Hepatology. 2017 Jul;66(1):152-166.
Title: Hepatic IFIT3 predicts interferon-alpha therapeutic response in patients of hepatocellular carcinoma.
Author: Yang, Yingyun|Zhou, Ye|Hou, Jin|Bai, Chunmei|Li, Zhenyang|Fan, Jia|Ng, Irene O L|Zhou, Weiping|Sun, Huichuan|Dong, Qiongzhu|Lee, Joyce M F|Lo, Chung-Mau|Man, Kwan|Yang, Yun|Li, Nan|Ding, Guoshan|Yu, Yizhi|Cao, Xuetao
PMID: 28295457
Journal: PLoS Pathog. 2017 Apr 10;13(4):e1006321.
Title: GP73 represses host innate immune response to promote virus replication by facilitating MAVS and TRAF6 degradation.
Author: Zhang, Xuewu|Zhu, Chengliang|Wang, Tianci|Jiang, Hui|Ren, Yahui|Zhang, Qi|Wu, Kailang|Liu, Fang|Liu, Yingle|Wu, Jianguo
PMID: 28394926